Tag: Lutonix DCB
More mixed results for DCBs in AV access maintenance as evidence...
Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...
FDA notifies BD that Lutonix paclitaxel balloon PMA application for below...
The US Food and Drug Administration (FDA) have denied BD premarket approval (PMA) for the company’s Lutonix drug-coated balloon (DCB) in the treatment of...
ULTRASCORE scoring helps obtain luminal gain at low inflation pressure before...
Dierk Scheinert (Leipzig, Germany) talks to Vascular News at LINC 2019 about the importance of vessel preparation with adjunctive therapies such as the use...
